RecallDepth
Class II Terminated

Moexipril Hydrochloride and Hydrocholorothiazide Tablets USP, 7.5 mg/12.5 mg, 100-count bottle, Rx only, Distributed By: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5213-01.

Company
Teva Pharmaceuticals Usa
Recall Initiated
December 14, 2017
Posted
January 17, 2018
Recall Number
D-0208-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4,969 bottles
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Impurities/Degradation Specifications: High out of specification test result for the Moexipril Diketopiperazine impurity was obtained during routine stability testing.

Distribution

Nationwide in the USA

Lot / Code Info

Lot # 30229439A, Exp 12/17

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls